Search for a command to run...
Promoter shareholding in Bliss GVS Pharma Ltd. increased slightly YoY and QoQ (0.54% YoY, 0.16% QoQ), suggesting some insider confidence.
Institutional shareholding decreased significantly both YoY (-2.42%) and QoQ (-0.66%), indicating a lack of institutional interest compared to a neutral sector average.
Public shareholding showed a marginal increase (0.19% YoY), but overall trends reflect a broader sector decline, aligning with the title of Broad-Based Selling.
| Category | Trend | Dec 2023 | Mar 2024 | Jun 2024 | Sep 2024 | Dec 2024 | Mar 2025 | Jun 2025 | Sep 2025 |
|---|---|---|---|---|---|---|---|---|---|
1Promoter Holdings | 34.97% | 34.97% | 34.9% | 34.82% | 35.1% | 35.29% | 35.44% | 35.39% | |
2Public Holdings | 43.07% | 43.71% | 45.27% | 46.48% | 44.84% | 44.98% | 45.37% | 45.36% | |
3Foreign Investors | 15.36% | 14.74% | 13.24% | 12.13% | 13.51% | 13.18% | 12.65% | 13.27% | |
4Domestic Investors | 6.6% | 6.58% | 6.59% | 6.57% | 6.55% | 6.55% | 6.54% | 5.98% |